1072-67-9, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1072-67-9, name is 5-Methylisoxazol-3-amine, introducing its new discovery.
Indoline-1- N-carboxamide compound, preparation method thereof and application thereof in medicine and pharmacy (by machine translation)
The invention relates to a novel indoline (indoline)-formamide compound for regulating or inhibiting (VEGFR) the activity of vascular endothelial cell growth factor receptors and a preparation method and application thereof in medicine and pharmacy. In particular, the present invention relates to a pharmaceutical (I) composition comprising the compound or a pharmaceutically acceptable salt thereof, a compound or a pharmaceutically acceptable salt thereof, a compound or a pharmaceutically acceptable salt thereof, and a method for preparing/the compound VEGFR or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable salt thereof. The present invention also relates to the use of said compound or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising said compound or a pharmaceutically acceptable salt thereof in/the manufacture VEGFR of a medicament for the treatment and/or prevention of a mediated disease, in particular a tumor. Where the substituents of (I) the general formula I are the same as defined in the specification. (by machine translation)
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.1072-67-9, you can also check out more blogs about1072-67-9
Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem